Historical
CLSI EP14-A2
Evaluation of Matrix Effects; Approved Guideline - Second Edition
This document provides guidance for evaluating the bias in analyte measurements that is due to the sample matrix (physiological or artificial) when two measurement procedures are compared. The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.
Content Provider
Clinical And Laboratory Standards Institute [clsi]
